VYNE Research and Charts

VYNE - VYNE Therapeutics Inc (Healthcare: Biotechnology)

Projected Earnings Date: 0000-02-29 (Delayed quote data 2026-02-10)

Last 0.56	Change ⇓ 0.00 (0.00%)	Volume 259,359
	Open 0.57	High 0.57	Low 0.55

8EMA (Daily) 0.56	40EMA (Daily) 0.54	50EMA (Daily) 0.53	STO (Daily) 35.000	MACD Hist (Daily) -0.004
8EMA (Weekly) 0.549	40EMA (Weekly) 0.77	50EMA (Weekly) 0.90	STO (Weekly) 57.243	MACD Hist (Weekly) 0.029


Company Profile
VYNE Therapeutics Inc is a biopharmaceutical company which focuses on the development and commercialization of variety of solutions using its proprietary Molecule Stabilizing Technology. The company is developing products which will help improve lives of the patients with dermatological diseases. Its pipeline includes Amzeeq and Zilxi.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.